½ºÆä·ÎÀÌµå ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : À¯Çüº°, ¹æ¹ýº°, °ø±Þ¿øº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Spheroids Market Size, Share & Trends Analysis Report By Type, By Method, By Source, By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine), By End Use, By Region And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1750886
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,146,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,515,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,253,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ºÆä·ÎÀÌµå ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ ½ºÆä·ÎÀÌµå ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 24¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2030³âÀÇ CAGRÀº 22.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ±âÁ¸ 2Â÷¿ø ¹è¾çº¸´Ù »ý¸®ÇÐÀûÀ¸·Î ´õ ÀûÇÕÇÑ Á¶°ÇÀ» Á¦°øÇÏ´Â °í±Þ 3Â÷¿ø ¼¼Æ÷¹è¾ç ¸ðµ¨¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ Å« °ßÀÎÂ÷ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¼¼Æ÷ ±¸Á¶, ¿µ¾ç ±¸¹è, »ýü Á¶Á÷ÀÇ ¹Ì¼¼ ȯ°æÀ» ´õ Àß ¸ð¹æÇϰí, ¾à¹° ½ºÅ©¸®´×, Áúº´ ¸ðµ¨¸µ, µ¶¼º Å×½ºÆ®, Àç»ý ÀÇÇп¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß ¹× Á¦¾àȸ»ç´Â ÀǾàǰ °³¹ßÀÇ ¼º°ø·üÀ» ³ôÀ̰í Èı⠴ܰèÀÇ ½ÇÆÐ¸¦ ÁÙÀ̱â À§ÇØ º¸´Ù Á¤È®ÇÑ ÀüÀÓ»ó ¸ðµ¨À» ¿ì¼±½ÃÇϰí ÀÖÀ¸¸ç, ±× Àû¿ë ¹üÀ§´Â Á¾¾çÇÐ, ½Å°æÇÐ, ´ë»ç¼º Áúȯ µî ±¤¹üÀ§ÇÑ Ä¡·á ºÐ¾ß¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù.

Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ÀÌ ´ë±Ô¸ð È­ÇÕ¹° ¶óÀ̺귯¸®¸¦ ´õ ³ôÀº ¿¹Ãø°ªÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ´Â ÇÏÀ̽º·çDz ½ºÅ©¸®´×(HTS) ½Ã½ºÅÛ¿¡ ½ºÆä·ÎÀ̵带 ÅëÇÕÇÏ´Â °Íµµ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀúÁ¡Âø¼º Ç÷¹ÀÌÆ®, ÇàÀ× µå·Ó ½Ã½ºÅÛ, ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º Ç÷§Æû°ú °°Àº »õ·Î¿î Åø ¹× ±â¼ú °³¹ß·Î ±¸Ã¼ÀÇ Á¦ÀÛÀ» °£¼ÒÈ­Çϰí ÀçÇö¼ºÀ» Çâ»ó½ÃŰ´Â »õ·Î¿î Åø ¹× ±â¼ú °³¹ßµµ ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤ºÎ ±â°ü ¹× ¹Î°£ ÅõÀÚÀÚµéÀÇ ÀÚ±Ý Áö¿ø Áõ°¡´Â Çмú ¹× »ó¾÷Àû ȯ°æ¿¡¼­ 3D ¹è¾ç ¿¬±¸ÀÇ È®´ë¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀº ƯÈ÷ ¹ÙÀÌ·¯½ºÇÐ ¹× ¸é¿ªÇÐ ¿¬±¸ ºÐ¾ß¿¡¼­ ½ºÇÇ·ÎÀÌµå ¸ðµ¨ÀÇ Ã¤ÅÃÀ» ´õ¿í °¡¼ÓÈ­½ÃÄ×½À´Ï´Ù. ¿¬±¸ÀÚµéÀÌ Àΰ£ Á¶Á÷À» º¸´Ù Ãæ½ÇÇÏ°Ô ÀçÇöÇÒ ¼ö ÀÖ´Â ¸ðµ¨À» ã°í ÀÖ´Â °¡¿îµ¥, ½ºÇÇ·ÎÀ̵å´Â SARS-CoV-2 °¨¿° ¸ÞÄ¿´ÏÁò, ¼÷ÁÖ ¸é¿ª ¹ÝÀÀ, Ç×¹ÙÀÌ·¯½ºÁ¦ È¿´ÉÀ» ¿¬±¸ÇÏ´Â µ¥ À¯¿ëÇÏ´Ù´Â °ÍÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ÆÒµ¥¹ÍÀº º¹ÀâÇÑ Áúº´À» ºü¸£°Ô ÀÌÇØÇÏ´Â µ¥ ÀÖÀ¸¸ç, ±âÁ¸ 2D ¹è¾ç ¹× µ¿¹° ¸ðµ¨ÀÇ ÇѰ踦 ºÎ°¢½ÃÄ×°í, ÀÌ´Â ±¸Ã¼¸¦ Æ÷ÇÔÇÑ 3D ¹è¾ç ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î À̾îÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ¶ÇÇÑ ¿¬±¸½ÇµéÀÌ ¹Ì·¡ÀÇ ¿¬±¸ ±â¹ÝÀ» È®º¸Çϱâ À§ÇØ Ã·´Ü ¹è¾ç ½Ã½ºÅÛÀ» äÅÃÇÏ°Ô µÇ¸é¼­ Àå±âÀûÀÎ ½ÃÀå ¼ºÀåÀ» Áö¿øÇß½À´Ï´Ù.

ÆÒµ¥¹Í ÀÌÈÄ¿¡µµ Àü ¼¼°è¿¡¼­ º¸´Ù À±¸®ÀûÀ̰í È¿À²ÀûÀÎ ÀüÀÓ»ó½ÃÇè Àü·«¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ±¸Ã¼ÀÇ ±â¼¼´Â °è¼ÓµÇ°í ÀÖ½À´Ï´Ù. ±ÔÁ¦±â°ü°ú ¿¬±¸ ±â°üÀº µ¿¹° ½ÇÇèÀ» ÁÙÀ̸鼭 Áß°³ ¿¬±¸ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÀÖÀ¸¸ç, ½ºÆä·ÎÀÌµå ¹× ±âŸ 3D ¸ðµ¨ÀÇ °¡Ä¡¸¦ Á¡Á¡ ´õ ¸¹ÀÌ ÀνÄÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ÂÃãÇü ÀÇ·áÀÇ ºÎ»ó°ú ȯÀÚ À¯·¡ ¼¼Æ÷¸¦ »ç¿ëÇÏ¿© Áúº´¿¡ ƯȭµÈ ±¸Ã¼¸¦ Çü¼ºÇÏ´Â °ÍÀº ¸ÂÃãÇü ÀǾàǰ °³¹ß ¹× Ä¡·á ½ÃÇè¿¡ »õ·Î¿î ±âȸ¸¦ ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇÕÇÏ¿©, ½ºÆä·ÎÀÌµå ½ÃÀåÀº ¾ÕÀ¸·Îµµ °ß°íÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ºÆä·ÎÀÌµå ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ½ºÆä·ÎÀÌµå ½ÃÀåÀÇ º¯¼ö¿Í µ¿Çâ

Á¦4Àå À¯Çüº° ºñÁî´Ï½º ºÐ¼®

Á¦5Àå ¹æ¹ýº° ºñÁî´Ï½º ºÐ¼®

Á¦6Àå °ø±Þ¿øº° ºñÁî´Ï½º ºÐ¼®

Á¦7Àå ÃÖÁ¾ ¿ëµµº° ºñÁî´Ï½º ºÐ¼®

Á¦8Àå ¿ëµµº° ºñÁî´Ï½º ºÐ¼®

Á¦9Àå Áö¿ªº° ºñÁî´Ï½º ºÐ¼®(±¹°¡º°, À¯Çüº°, ¹æ¹ýº°, °ø±Þ¿øº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°)

Á¦10Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Spheroids Market Growth & Trends:

The global spheroids market size is expected to reach USD 2.46 billion by 2030 and is anticipated to grow at a CAGR of 22.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has gained significant traction due to the growing demand for advanced 3D cell culture models that offer more physiologically relevant conditions than traditional 2D cultures. Spheroids, which better mimic the cellular architecture, nutrient gradients, and microenvironment of tissues in vivo, are increasingly used in drug screening, disease modeling, toxicology testing, and regenerative medicine. Their application spans a wide range of therapeutic areas, including oncology, neurology, and metabolic diseases, as researchers and pharmaceutical companies prioritize more accurate preclinical models to improve drug development success rates and reduce late-stage failures.

Another major driver is the integration of spheroids into high-throughput screening (HTS) systems, enabling pharmaceutical and biotechnology companies to evaluate large compound libraries with greater predictive value. The market is also fueled by developing novel tools and technologies such as low-attachment plates, hanging drop systems, and microfluidic platforms that simplify spheroid generation and improve reproducibility. In addition, increased funding from government agencies and private investors has supported the expansion of 3D culture research in academic and commercial settings.

The COVID-19 pandemic further accelerated the adoption of spheroid models, particularly in virology and immunology research. As researchers sought models that more closely represented human tissues, spheroids proved valuable for studying SARS-CoV-2 infection mechanisms, host immune responses, and antiviral drug efficacy. The pandemic highlighted the limitations of conventional 2D cultures and animal models in rapidly understanding complex diseases, leading to increased investment in 3D culture technologies, including spheroids. This shift also supported long-term market growth as laboratories increasingly adopted advanced culture systems to future-proof research infrastructure.

Post-pandemic, the momentum around spheroids has continued, driven by a global push toward more ethical and efficient preclinical testing strategies. Regulatory agencies and research institutions increasingly recognize the value of spheroids and other 3D models in reducing animal testing while improving translational outcomes. Furthermore, the rise of personalized medicine and the use of patient-derived cells to form disease-specific spheroids are opening new opportunities for customized drug development and therapeutic testing. Together, these factors are shaping a robust outlook for the market in the years ahead.

Spheroids Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Spheroids Market Variables and Trends

Chapter 4. Type Business Analysis

Chapter 5. Method Business Analysis

Chapter 6. Source Business Analysis

Chapter 7. End Use Business Analysis

Chapter 8. Application Business Analysis

Chapter 9. Regional Business Analysis, by Country, Type, Method, Source, Application, & End Use

Chapter 10. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â